Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

Published:2023-03-17 Issue:12 Volume:71 Page:1637-1646
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Tenforde Mark W.,Weber Zachary A.,Natarajan Karthik,Klein Nicola P.,Kharbanda Anupam B.,Stenehjem Edward,Embi Peter J.,Reese Sarah E.,Naleway Allison L.,Grannis Shaun J.,DeSilva Malini B.,Ong Toan C.,Gaglani Manjusha,Han Jungmi,Dickerson Monica,Fireman Bruce,Dascomb Kristin,Irving Stephanie A.,Vazquez-Benitez Gabriela,Rao Suchitra,Konatham Deepika,Patel Palak,Schrader Kristin E.,Lewis Ned,Grisel Nancy,McEvoy Charlene,Murthy Kempapura,Griggs Eric P.,Rowley Elizabeth A. K.,Zerbo Ousseny,Arndorfer Julie,Dunne Margaret M.,Goddard Kristin,Ray Caitlin,Zhuang Yan,Timbol Julius,Najdowski Morgan,Yang Duck-Hye,Hansen John,Ball Sarah W.,Link-Gelles Ruth

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference10 articles.

1. Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022.;Rosenblum;MMWR Morb Mortal Wkly Rep,2022

2. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant.;Lopez Bernal;N Engl J Med,2021

3. Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 states, August 2021–January 2022.;Thompson;MMWR Morb Mortal Wkly Rep,2022

4. Effectiveness of COVID-19 mRNA vaccines against COVID-19–associated hospitalizations among immunocompromised adults during SARS-CoV-2 Omicron predominance—VISION Network, 10 states, December 2021–August 2022.;Britton;MMWR Morb Mortal Wkly Rep,2022

5. Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during BA.4 and BA.5 sublineage periods.;Link-Gelles;medRxiv [Preprint posted online October 5,,2022

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-specific causal effects of serum sex hormones on COVID-19 susceptibility and severity: Evidence from the UK Biobank and COVID-19 Host Genetics Initiative;Computational and Structural Biotechnology Reports;2024-12

2. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

3. Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds;Journal of the Pediatric Infectious Diseases Society;2024-06-11

4. A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants;Vaccine;2024-05

5. Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System;2024-04-07